Cite
Ornello R, Ahmed F, Negro A, et al. Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study. Pain Ther. 2021;10(1):637-650doi: 10.1007/s40122-021-00253-0.
Ornello, R., Ahmed, F., Negro, A., Miscio, A. M., Santoro, A., Alpuente, A., Russo, A., Silvestro, M., Cevoli, S., Brunelli, N., Vernieri, F., Grazzi, L., Baraldi, C., Guerzoni, S., Andreou, A. P., Lambru, G., Frattale, I., Kamm, K., Ruscheweyh, R., Russo, M., Torelli, P., Filatova, E., Latysheva, N., Gryglas-Dworak, A., Straburzynski, M., Butera, C., Colombo, B., Filippi, M., Pozo-Rosich, P., Martelletti, P., & Sacco, S. (2021). Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study. Pain and therapy, 10(1), 637-650. https://doi.org/10.1007/s40122-021-00253-0
Ornello, Raffaele, et al. "Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study." Pain and therapy vol. 10,1 (2021): 637-650. doi: https://doi.org/10.1007/s40122-021-00253-0
Ornello R, Ahmed F, Negro A, Miscio AM, Santoro A, Alpuente A, Russo A, Silvestro M, Cevoli S, Brunelli N, Vernieri F, Grazzi L, Baraldi C, Guerzoni S, Andreou AP, Lambru G, Frattale I, Kamm K, Ruscheweyh R, Russo M, Torelli P, Filatova E, Latysheva N, Gryglas-Dworak A, Straburzynski M, Butera C, Colombo B, Filippi M, Pozo-Rosich P, Martelletti P, Sacco S. Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study. Pain Ther. 2021 Jun;10(1):637-650. doi: 10.1007/s40122-021-00253-0. Epub 2021 Mar 28. PMID: 33778933; PMCID: PMC8119503.
Copy
Download .nbib